Description
Tesamorelin is a stabilized synthetic analog of Growth Hormone-Releasing Factor (GRF) consisting of all 44 amino acids of human GHRH, modified with a trans-3-hexenoic acid group at the N-terminus. This modification extends its half-life and stability. The compound has been extensively researched to prove to stimulate the synthesis and pulsatile release of endogenous growth hormone from the pituitary gland. In research settings, Tesamorelin is primarily investigated for its specific ability to target and reduce visceral adipose tissue (VAT) and improve lipid profiles in models of lipodystrophy, without significantly altering glucose parameters compared to other secretagogues.
Ingredients
-
Active Agent: Tesamorelin Acetate (Modified GHRH 1-44)
-
Format: Sterile Lyophilized Powder (requires reconstitution)
-
Concentration: 5mg per vial
-
Purity: ≥99% (HPLC Verified)
-
Sequence: trans-3-Hexenoyl-[Tyr1]hGRF(1-44)NH2
